| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Insulin Glargine |
| Brand | Abasaglar® |
| Indication | For the treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above. |
| Assessment Process | |
| Rapid review commissioned | 04/09/2015 |
| Rapid review completed | 12/10/2015 |
| Rapid review outcome | Full Pharmacoeconomic Assessment Not Recommended |